Doctors worldwide may encounter extra-intestinal (tissue) helminthiasis when working in endemic regions or when treating visitors returning from endemic regions, immigrants or patients who have resided in tropical countries.
Malaria, leishmaniasis, trypanosomiasis and amoebiasis are important diseases worldwide and account for significant morbidity and mortality in Africa, Asia as well as Central and South America. Doctors worldwide may encounter these diseases when working in endemic regions or when treating visitors to endemic regions, immigrants or patients who have resided in tropical countries.
Intestinal helminths are very common parasites found worldwide (about 3 billion carriers in total). Enterobiasis (pinworm/threadworm infection) is a common condition in children but can also affect adults. It appears that the incidence of pinworm infection has increased particularly in the industrialised countries, where other helminthic diseases are relatively rare.
Issues in Life Sciences: Bacteriology, Parasitology, and Virology: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Life Sciences—Bacteriology, Parasitology, and Virology. The editors have built Issues in Life Sciences: Bacteriology, Parasitology, and Virology: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Life Sciences—Bacteriology, Parasitology, and Virology in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Issues in Life Sciences: Bacteriology, Parasitology, and Virology: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.
This book presents a comprehensive and up to date account of the chemotherapy of parasitic diseases, both human and veterinary. The book starts with an overview of parasitic diseases. The body of the book is divided into two parts: antihelminthic drugs, and antiprotozoal drugs. Both parts start with chapters highlighting the 'biochemical targets' available for chemotherapeutic interference. Individual chapters deal with one chemical class of compounds and describe their origin, structure-activity relationship, mode of action, and methods of synthesis and their status both in clinical and veterinary practice. The book will be useful to a wide spectrum of readers: students embarking on a research career in parasitic chemotherapy, clinicians (and veterinarians) and clinical pharmacologists desiring detailed information about the drugs currently in use, and pharmaceutical technologists wanting to update their knowledge of the methods of manufacture.
The type 2 immune response that develops during infectious disease has undergone major paradigm shifts in the last several years as new cell types and pathways have been identified. It is now clear that the type 2 immune response, characterized by elevations in specific cytokines, including IL-4, IL-5 and IL-13, is associated with helminth infections in both humans and mice. This response is complex and includes effector functions that mediate resistance, contributing to expulsion and in some cases destruction, of the parasite. But just as importantly, the type 2 immune response can also mediate tolerance mechanisms, which can mitigate tissue injury as these large multicellular parasites transit through vital organs. The tolerance mechanisms include both tissue repair and immune regulatory effects. These latter aspects of the helminth-induced type 2 immune response are increasingly recognized as a potential resource that can be mined for the development of novel immunotherapies that may enhance wound healing, control of autoimmune and inflammatory diseases and regulation of metabolic homeostasis. In this book, leading researchers in this exciting and dynamic field discuss the latest findings and emerging concepts, providing an intellectual framework that can be used as a basis for new discoveries and potentially new treatments for diseases associated with inflammation.
Amid recent changes in global health, the public interest in travelers' safety has never been greater. For both international travelers and the health professionals who care for them, CDC Health Information for International Travel (more commonly known as The Yellow Book) is the definitive resource for preventing illness and injury in a globalized world. This 2016 edition offers the US government's most current health recommendations for travelers to international destinations, including disease risk maps, country-specific guidelines, and vaccine requirements and recommendations. The book also offers updated guidance for specific types of travel and travelers, including: Precautions for immunocompromised travelers and disabled travelers Guidance for the pregnant, last-minute, or resource-limited traveler Health considerations for newly arrived adoptees, immigrants, and refugees Advice for air crews, humanitarian aid workers, and health care workers traveling to provide care overseas Written by a team of experts at CDC on the forefront of travel medicine, The Yellow Book provides a user-friendly, vital resource for those in the business of keeping travelers healthy abroad.
This bibliography is an attempt to list all the publications dealing with helminth of waterfowl (Anatidae) -- reports of their occurrence, descriptions, classification, life history, and pathological effects. It brings up-to-date and revises the work published on microfilm in 1965 (Wildlife Disease, No. 45). Studies on prophylaxis and treatment and on physiology, and general manuals and texts on poultry diseases are omitted. Publications issued before 1890 (numbering about 120) are also omitted as the information in many of these is incomplete and the identification dubious.
When Professor John Sprent first suggested, in 1982, that the Australian Society for Parasitology should bid for the opportunity to mount the Sixth International Congress of Parasitology, the immediate reaction was one of disbelief. However, in the two years or so before ICOPA 5, in Toronto, he used his considerable powers to the utmost and spent himself unstintingly in persuading Australian parasitologists to put together a bid. The Society inevitably agreed, for it is difficult to prevent such a determined and eminent man from getting his own way! A case for an Australian venue was prepared and, as President, I was charged with the task of convincing the delegates in Toronto that Australia was worth going all the way to see. The events of that meeting are now far in the past; suffice to say that, in the end, Australia won by the narrowest of margins, largely due to the energy of my inventive colleagues who put the case for Australia at every possible and improbable moment. I do not remember a great deal about the scientific aspects of ICOPA 5. I was far too preoccupied with an awful spectre, that of telling John Sprent that I had failed, to pay attention to much other than lobbying for votes. I do remember, however, telling myself how much I would enjoy the next ICOPA without the terrible responsibility of capturing ICOPA 7.
Using an integrated approach, this singular text focuses on patient first, helping you consider each patient as a unique individual with specific health concerns and characteristics that affect therapeutic decision making and drug efficacy. Organized by disease state, this book will introduce you to general drug classifications and the medicinal agents most likely to be encountered in primary care settings. It encompasses the pharmacological principals, dosing, patient education, pharmacodynamics, and therapeutic parameters and indications for commonly prescribed drugs.
This book aims to provide fundamental knowledge and information for research in molecular systematics on parasitic helminths (nematode, trematode, cestode). The shreds of evidence of molecular systematics studies will be compiled and discussed in terms of the utilities and pitfalls of the genetic marker used for various purposes, which have been implemented for molecular systematics of parasitic nematodes, cestodes, and trematodes. Moreover, this book will also provide the procedure for research on molecular systematics and DNA taxonomy as the guideline to explore parasitic helminths. Finally, the further perspectives of utilizing genetic markers for molecular studies on parasitic helminths will be addressed in the context of applications from the laboratory to fieldwork such as DNA barcoding and environmental DNA metabarcoding of parasitic helminths. The book will benefit postgraduate students and researchers requiring the detailed knowledge of molecular systematics, as well as researchers desiring a guideline to select genetic markers and analyze DNA sequences to make phylogenetic inferences